Name: Challenges to Precision Medicine for Anti-Cancer Immunotherapy: When Other Combos w/ Anti-PD-1 Are Active, Mechanisms May Be Redundant w anti-CTLA-4
Uploaded: 2019-11-28T18:36:30.720407+00:00
Duration: 34 min 10 s
Description: Challenges to Precision Medicine for Anti-Cancer Immunotherapy: When Other Combos w/ Anti-PD-1 Are Active, Mechanisms May Be Redundant w anti-CTLA-4